Posts Tagged ‘Venture Capital’
Makower: Making Medtech Bigger, Stronger, Faster
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 054″] Josh Makower, MD, literally wrote (or co-wrote) the book on Medtech Innovation. Makower is a general partner in New Enterprise Associates most recent fund, but he’s worked with the firm as a Venture Partner or EIR since 1995. Makower founded ExploraMed I, II, III, and IV Inc., a series of…
Read MoreYear 1: What OIS Podcasts Were Most Popular? Part Two
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 051″] We’re thrilled to be celebrating the one-year anniversary of the OIS Podcast. We hope you enjoyed these tales of innovation as much as we have. To celebrate milestone we reveal and review the interviews that most resonated with our listeners. We reviewed numbers Six through Ten in our last episode.…
Read MoreYear 1: What OIS Podcasts Were Most Popular? Part One
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 050″] We’re thrilled to be celebrating the one-year anniversary of the OIS Podcast. We hope you enjoyed these tales of innovation as much as we have. To celebrate milestone we reveal and review the interviews that most resonated with our listeners. Transcripts Tom Salemi: Hello, everyone, welcome back to the OIS…
Read MoreClarus Delivers Good News With $500m Fund
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 048″] OIS Co-Chair Emmett Cunningham explains how Clarus will invest new $500m fund in ophthalmology and beyond. Podcast Guest Emmett T. Cunningham Jr., MD, PhD, MPH Dr. Cunningham joined Clarus Ventures with 20+ years in the biomedical and biopharmaceutical sectors. Prior, Dr. Cunningham was the SVP, Medical Strategy at Eyetech Pharmaceuticals.…
Read MoreAlternative Financing Approaches
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 036″] As venture investors shift to later stages, start-ups will have to look harder for new sources of innovation. A panel at OIS@ASCRS discusses how new sources of capital can sustain the creation of new companies.
Read MoreAlternative Financing Approaches
Moderator: Tom Salemi Tom serves as Content Director for Healthegy, joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products. View Full Profile Panelists: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President…
Read MoreOphthalmology By The Numbers With Jon Norris of SVB
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 026″] Jon Norris, Managing Director of Health Care at Silicon Valley Bank, gives a sneak peak on his coming report on the health care sector and discusses why ophthalmology continues to be a strong source of innovation. Podcast Guest Jonathan Norris Jon Norris is a Managing Director with SVB Healthcare team,…
Read MoreQ&A with Richard Lindstrom
First adopter Richard Lindstrom, MD, details the role new technology play in ophthalmology. Speaking With: Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinical Professor Emeritus at the University of Minnesota Department of Ophthalmology, Associate Director: Minnesota Lions Eye Bank, Board Member: University of Minnesota Foundation, and…
Read MoreKliman: Ophthalmology Is A “Leading Franchise” At InterWest
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 006″] OIS Co-Chair, Gil Kliman, MD, Managing Director at InterWest Partners, delivers insight on his firm’s decision to concentrate on ophthalmology fifteen years ago and shares the many lessons he’s learned during that time. Podcast Guest Gilbert H. Kliman, MD Dr. Gil Kliman leads the medical device investment team at InterWest…
Read MoreLink Says Versant’s Eyes Will Be On Ophthalmology
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 002″] Bill Link explains why ophthalmology will continue to be a pillar for Versant’s new fund. He also talks about the impact of industry consolidation, the Sunshine Act, and he offers helpful advice to entrepreneurs and physicians looking to turn inspiration into innovation. Podcast Guest William J. Link, PhD Bill was…
Read MoreEyeSonix
Donald Schwartz talks about TUG, which is the only ultrasound treatment designed for all open angle glaucoma. Presenter: Donald Schwartz Donald Schwartz is a comprehensive ophthalmologist in practice in Long Beach CA. He is on the clinical faculty of both USC and UC Irvine where he has taught cataract surgery and optics and refraction for…
Read MoreBill Link Dives into his Perspective of Venture Overseas
William J. Link PhD, Managing Director for Versant Ventures, gives the audience at the 5th Annual Ophthalmology Innovation Summit a look into the returns on the venture investing side and the comparison between the US and Europe. Utilizing specific data and numbers, Bill continues to share his personal biases as an American in the US…
Read More